First HD multifocal lens for presbyopia and astigmatism

Article

opcon has launched the LENTIS Mplustoric intraocular lens (IOL.

Topcon has launched the LENTIS Mplustoric intraocular lens (IOL, designed to provide astigmatic patients the advanced benefits of Topcon's patented high-definition LENTIS Mplus technology. The company will officially present the lens to the market at the United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS) meeting in Brighton 11-12 November.

The LENTIS Mplustoric combines Topcon's LENTIS Mplus lens with the toric functionalities of the Tplus series. The LENTIS Mplus, which launched in July 2009, has been fitted in over 3,000 patients across the UK. Clinical trials have shown a reported rate of 95% patient satisfaction. Unlike other multifocal IOLs (MIOLs), it has a unique sector-shaped near-vision segment and uses only one transition zone, allowing, claims Topcon, for seamless transition between the near, intermediate and far vision zones and minimal to no risk of halos and glare in patient vision.

Professor Sunil Shah, Consultant Ophthalmologist at the Midland Eye Institute comments: “The LENTIS Mplustoric is simply the best all-in-one lens solution combining presbyopia correction with astigmatism. It is a major technical step forward for the IOL industry as it is the best combination of two highly advanced technologies. This lens has enabled us to better correct the vision of a wider range of patients and the outcomes have so far been remarkable.”

Gloria McCall, Topcon Surgical adds, “Topcon is excited about the launch of the LENTIS Mplustoric and looks forward to presenting it to the UK's top ophthalmologists at the UKISCRS meeting in November. The new lens offers high-definition glass-free vision to patients who would previously not have been suitable for our leading LENTIS Mplus design.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.